ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

BLTE Belite Bio Inc

43,20
2,10 (5,11%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Belite Bio Inc BLTE NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
2,10 5,11% 43,20 06:00:09
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
41,05 40,88 43,45 43,20 41,10
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202422:15GLOBEBelite Bio Announces Presentation at the Association for..
26.4.202401:15GLOBEBelite Bio Announces $25 Million Registered Direct Offering
22.3.202413:00GLOBEBelite Bio Announces PMDA Submission of Tinlarebant for..
12.3.202403:28GLOBEBelite Bio Announces Availability of Annual Report on Form..
12.3.202402:27GLOBEBelite Bio Reports Fourth Quarter and Full Year 2023..
06.3.202414:00GLOBEBelite Bio to Host Webcast on March 12, 2024, to Discuss..
04.3.202414:00GLOBEBelite Bio to Participate in the Leerink Partners Global..
13.2.202403:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13.2.202402:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07.2.202414:00GLOBEBelite Bio to Present at the Oppenheimer 34th Annual..
28.12.202322:16EDGAR2Form 144 - Report of proposed sale of securities
28.12.202322:15EDGAR2Form 144 - Report of proposed sale of securities
30.11.202314:00GLOBEBelite Bio to Participate in the Benchmark Company’s..
28.11.202323:16EDGAR2Form 144 - Report of proposed sale of securities
20.11.202314:00GLOBEBelite Bio to Participate in the BTIG Ophthalmology Day
16.11.202322:41EDGAR2Form 144 - Report of proposed sale of securities
16.11.202322:36EDGAR2Form 144 - Report of proposed sale of securities
14.11.202302:15GLOBEBelite Bio Reports Third Quarter 2023 Operational Highlights..
10.11.202314:35GLOBEDeutsche Bank ADR Investor Conference: Presentations Now..
07.11.202314:00GLOBEBelite Bio to Host Webcast on November 14, 2023, to Discuss..
06.11.202322:00GLOBEBelite Bio, Inc. to present at the Deutsche Bank ADR Virtual..
06.11.202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06.11.202314:00GLOBEBelite Bio Presents Results from a 24-month, Phase 2 Study..
01.11.202313:35GLOBEInternational companies to host live webcasts at Deutsche..
27.10.202314:00GLOBEBelite Bio Announces Presentation at the American Academy of..
19.9.202318:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
31.8.202323:16EDGAR2Form 144 - Report of proposed sale of securities
31.8.202322:48EDGAR2Form 144 - Report of proposed sale of securities
09.8.202312:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24.7.202312:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock